Treatment Options for Neuropathy After Reverse Total Shoulder Arthroplasty
The first-line treatment for neuropathy after reverse total shoulder arthroplasty should include gabapentin or pregabalin, which are effective for managing neuropathic pain with good evidence for efficacy and tolerability. 1
Medication Options
First-Line Treatments
- Gabapentin and pregabalin are recommended as first-line treatments for neuropathic pain, acting by binding to the α-2-δ subunit of voltage-gated calcium channels 1
- Start with low doses and titrate gradually: gabapentin typically titrated to 2400 mg per day in divided doses 1
- Pregabalin can be started at 75 mg twice daily and titrated as needed up to 300-600 mg/day 1
- Dose adjustments are necessary in patients with renal impairment 1
Alternative First-Line Options
- Tricyclic antidepressants (TCAs) like nortriptyline and desipramine are effective first-line alternatives 1
- Start TCAs at low doses (10 mg/day) and titrate slowly to a maximum of 75 mg/day, especially in older adults 1
- Obtain a screening ECG for patients over 40 years before starting TCAs due to potential cardiac risks 1
- Selective serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine (60-120 mg/day) and venlafaxine (150-225 mg/day) have fewer anticholinergic effects than TCAs 1
Topical Treatments
- Consider 5% lidocaine patches for localized peripheral neuropathic pain, particularly with allodynia 1
- High-concentration capsaicin patches may be beneficial for localized neuropathic pain 1
Treatment Algorithm
Assess the type and location of neuropathy:
First-line treatment:
If partial response after adequate trial:
- Add another first-line agent from a different class (e.g., add duloxetine to gabapentin) 1
If inadequate response to first-line agents:
For refractory cases:
Special Considerations
- Most neurologic deficits after RTSA are temporary and resolve with conservative management - studies show complete recovery in most patients within an average of 7.4 months 2
- Neurologic deficit after RTSA occurs in approximately 19% of patients and is significantly correlated with humeral distalization after surgery 2
- Distal peripheral neuropathy (DPN) is an under-reported complication after shoulder surgery, with 12.3% of reverse shoulder arthroplasty patients developing DPN 5
- The most common form of DPN after RTSA is cubital tunnel syndrome 5
- Conservative treatment resolves symptoms in approximately 42.86% of RTSA patients with DPN, but 14.3% may require surgical decompression 5
- Surgical decompression is highly effective for refractory cases, with 100% of patients achieving complete resolution of symptoms after decompression 5
Monitoring and Follow-up
- Regular assessment of pain intensity, functional improvement, and adverse effects 1
- If substantial pain relief (≥50% reduction) is achieved with tolerable side effects, continue treatment 1
- For patients with ulnar nerve neuropathy after RTSA, electrodiagnostic and ultrasound studies should be performed to confirm and assess the site and severity of the injury 3
- Be aware that surgical intervention for ulnar nerve neuropathy following RTSA may have limited success, with complete symptom resolution in only a minority of patients 3